DePuy Synthes and Stryker lead the Australian bone graft substitutes market, according to analysis by iData Research.
Here are six key trends in the market:
1. The bone graft substitutes market is valued at over $21 million.
2. DePuy Synthes is the leading player in the market. The company is known for its tricalcium phosphate-based ChronOs portfolio and Norian.
3. DePuy also released the first commercial demineralized bone matrix product in the Australian market.
4. There was acceleration in the growth rate of procedures and average selling prices between 2012 and 2014, driven by the introduction and rapid commercial expansion of the DBM product.
5. Stryker is the second leading player in the market. The company is known for its tricalcium phosphate-based Vitoss and HAP-based HydroSet synthetic products.
6. Other players in the market include Zimmer Biomet, Medtronic and Wright Medical.